GO:0010467 | gene expression | 4.03e-05 | 3.93e-01 | 2.749 | 7 | 49 | 535 |
GO:0006369 | termination of RNA polymerase II transcription | 5.05e-05 | 4.93e-01 | 5.343 | 3 | 5 | 38 |
GO:0006379 | mRNA cleavage | 1.28e-04 | 1.00e+00 | 6.836 | 2 | 2 | 9 |
GO:0008380 | RNA splicing | 2.50e-04 | 1.00e+00 | 3.639 | 4 | 21 | 165 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.71e-04 | 1.00e+00 | 6.099 | 2 | 4 | 15 |
GO:0003723 | RNA binding | 1.15e-03 | 1.00e+00 | 3.057 | 4 | 22 | 247 |
GO:0004832 | valine-tRNA ligase activity | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0031124 | mRNA 3'-end processing | 2.05e-03 | 1.00e+00 | 4.876 | 2 | 4 | 35 |
GO:0003743 | translation initiation factor activity | 2.29e-03 | 1.00e+00 | 4.796 | 2 | 8 | 37 |
GO:0006406 | mRNA export from nucleus | 3.23e-03 | 1.00e+00 | 4.546 | 2 | 7 | 44 |
GO:0005829 | cytosol | 3.55e-03 | 1.00e+00 | 1.372 | 9 | 88 | 1787 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0034969 | histone arginine methylation | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0006353 | DNA-templated transcription, termination | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0044267 | cellular protein metabolic process | 4.19e-03 | 1.00e+00 | 2.546 | 4 | 14 | 352 |
GO:0006412 | translation | 4.65e-03 | 1.00e+00 | 3.115 | 3 | 12 | 178 |
GO:0005681 | spliceosomal complex | 5.01e-03 | 1.00e+00 | 4.224 | 2 | 8 | 55 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 2 | 3 |
GO:0016274 | protein-arginine N-methyltransferase activity | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0005853 | eukaryotic translation elongation factor 1 complex | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0008469 | histone-arginine N-methyltransferase activity | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0005739 | mitochondrion | 7.24e-03 | 1.00e+00 | 1.963 | 5 | 32 | 659 |
GO:0045292 | mRNA cis splicing, via spliceosome | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 2 | 4 |
GO:0072341 | modified amino acid binding | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0004521 | endoribonuclease activity | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0030529 | ribonucleoprotein complex | 1.09e-02 | 1.00e+00 | 3.648 | 2 | 5 | 82 |
GO:0050847 | progesterone receptor signaling pathway | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 4 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 4 | 7 |
GO:0005845 | mRNA cap binding complex | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0071949 | FAD binding | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 4 | 8 |
GO:0006413 | translational initiation | 1.56e-02 | 1.00e+00 | 3.376 | 2 | 6 | 99 |
GO:0010225 | response to UV-C | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 3 | 9 |
GO:0006397 | mRNA processing | 1.90e-02 | 1.00e+00 | 3.224 | 2 | 12 | 110 |
GO:0005095 | GTPase inhibitor activity | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 4 | 11 |
GO:0008023 | transcription elongation factor complex | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 1 | 11 |
GO:0005654 | nucleoplasm | 2.31e-02 | 1.00e+00 | 1.553 | 5 | 68 | 876 |
GO:0003746 | translation elongation factor activity | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 12 |
GO:0000398 | mRNA splicing, via spliceosome | 2.52e-02 | 1.00e+00 | 3.005 | 2 | 15 | 128 |
GO:0016575 | histone deacetylation | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 2 | 14 |
GO:0000188 | inactivation of MAPK activity | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 4 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 2 | 16 |
GO:0005782 | peroxisomal matrix | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 1 | 16 |
GO:0031047 | gene silencing by RNA | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 3 | 18 |
GO:0031397 | negative regulation of protein ubiquitination | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 18 |
GO:0006913 | nucleocytoplasmic transport | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 4.01e-02 | 1.00e+00 | 4.613 | 1 | 2 | 21 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 3 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 1 | 22 |
GO:0016071 | mRNA metabolic process | 4.24e-02 | 1.00e+00 | 2.596 | 2 | 10 | 170 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 6 | 24 |
GO:0004842 | ubiquitin-protein transferase activity | 4.66e-02 | 1.00e+00 | 2.522 | 2 | 17 | 179 |
GO:0009267 | cellular response to starvation | 4.94e-02 | 1.00e+00 | 4.305 | 1 | 1 | 26 |
GO:0016070 | RNA metabolic process | 5.09e-02 | 1.00e+00 | 2.451 | 2 | 10 | 188 |
GO:0005515 | protein binding | 5.39e-02 | 1.00e+00 | 0.581 | 12 | 198 | 4124 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 29 |
GO:0008094 | DNA-dependent ATPase activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 6 | 29 |
GO:0008026 | ATP-dependent helicase activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 3 | 29 |
GO:0005778 | peroxisomal membrane | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 3 | 29 |
GO:0006446 | regulation of translational initiation | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 2 | 29 |
GO:0008168 | methyltransferase activity | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 2 | 30 |
GO:0045111 | intermediate filament cytoskeleton | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 3 | 31 |
GO:0007254 | JNK cascade | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 5 | 35 |
GO:0044297 | cell body | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 5 | 35 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 4 | 38 |
GO:0005840 | ribosome | 7.51e-02 | 1.00e+00 | 3.684 | 1 | 2 | 40 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.51e-02 | 1.00e+00 | 3.684 | 1 | 4 | 40 |
GO:0000775 | chromosome, centromeric region | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 6 | 41 |
GO:0003684 | damaged DNA binding | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 41 |
GO:0005777 | peroxisome | 9.30e-02 | 1.00e+00 | 3.362 | 1 | 2 | 50 |
GO:0006334 | nucleosome assembly | 9.48e-02 | 1.00e+00 | 3.333 | 1 | 4 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 8 | 52 |
GO:0046872 | metal ion binding | 1.01e-01 | 1.00e+00 | 1.138 | 4 | 24 | 934 |
GO:0008584 | male gonad development | 1.05e-01 | 1.00e+00 | 3.173 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.07e-01 | 1.00e+00 | 3.147 | 1 | 5 | 58 |
GO:0005737 | cytoplasm | 1.12e-01 | 1.00e+00 | 0.643 | 8 | 127 | 2633 |
GO:0006464 | cellular protein modification process | 1.12e-01 | 1.00e+00 | 3.075 | 1 | 4 | 61 |
GO:0030018 | Z disc | 1.18e-01 | 1.00e+00 | 3.005 | 1 | 3 | 64 |
GO:0006414 | translational elongation | 1.26e-01 | 1.00e+00 | 2.897 | 1 | 2 | 69 |
GO:0030308 | negative regulation of cell growth | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 5 | 70 |
GO:0001649 | osteoblast differentiation | 1.35e-01 | 1.00e+00 | 2.796 | 1 | 5 | 74 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.41e-01 | 1.00e+00 | 1.592 | 2 | 23 | 341 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.52e-01 | 1.00e+00 | 2.613 | 1 | 5 | 84 |
GO:0006355 | regulation of transcription, DNA-templated | 1.58e-01 | 1.00e+00 | 1.109 | 3 | 31 | 715 |
GO:0044255 | cellular lipid metabolic process | 1.60e-01 | 1.00e+00 | 2.530 | 1 | 2 | 89 |
GO:0000209 | protein polyubiquitination | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.68e-01 | 1.00e+00 | 2.451 | 1 | 9 | 94 |
GO:0006457 | protein folding | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 5 | 97 |
GO:0042981 | regulation of apoptotic process | 1.97e-01 | 1.00e+00 | 2.198 | 1 | 4 | 112 |
GO:0044822 | poly(A) RNA binding | 2.00e-01 | 1.00e+00 | 0.948 | 3 | 45 | 799 |
GO:0007049 | cell cycle | 2.02e-01 | 1.00e+00 | 2.160 | 1 | 8 | 115 |
GO:0044212 | transcription regulatory region DNA binding | 2.45e-01 | 1.00e+00 | 1.846 | 1 | 13 | 143 |
GO:0005524 | ATP binding | 2.48e-01 | 1.00e+00 | 0.790 | 3 | 37 | 892 |
GO:0001701 | in utero embryonic development | 2.61e-01 | 1.00e+00 | 1.739 | 1 | 7 | 154 |
GO:0005874 | microtubule | 2.74e-01 | 1.00e+00 | 1.657 | 1 | 10 | 163 |
GO:0016567 | protein ubiquitination | 3.09e-01 | 1.00e+00 | 1.451 | 1 | 14 | 188 |
GO:0005743 | mitochondrial inner membrane | 3.21e-01 | 1.00e+00 | 1.383 | 1 | 9 | 197 |
GO:0006281 | DNA repair | 3.29e-01 | 1.00e+00 | 1.340 | 1 | 24 | 203 |
GO:0019899 | enzyme binding | 3.39e-01 | 1.00e+00 | 1.291 | 1 | 7 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 3.49e-01 | 1.00e+00 | 1.237 | 1 | 8 | 218 |
GO:0006200 | ATP catabolic process | 3.50e-01 | 1.00e+00 | 1.231 | 1 | 13 | 219 |
GO:0006508 | proteolysis | 4.06e-01 | 1.00e+00 | 0.961 | 1 | 11 | 264 |
GO:0008285 | negative regulation of cell proliferation | 4.21e-01 | 1.00e+00 | 0.892 | 1 | 11 | 277 |
GO:0005730 | nucleolus | 4.28e-01 | 1.00e+00 | 0.341 | 3 | 74 | 1217 |
GO:0055114 | oxidation-reduction process | 4.56e-01 | 1.00e+00 | 0.739 | 1 | 9 | 308 |
GO:0000278 | mitotic cell cycle | 4.63e-01 | 1.00e+00 | 0.711 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.66e-01 | 1.00e+00 | 0.697 | 1 | 17 | 317 |
GO:0042802 | identical protein binding | 5.05e-01 | 1.00e+00 | 0.538 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 5.27e-01 | 1.00e+00 | 0.447 | 1 | 21 | 377 |
GO:0016032 | viral process | 5.74e-01 | 1.00e+00 | 0.264 | 1 | 30 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.97e-01 | 1.00e+00 | 0.173 | 1 | 29 | 456 |
GO:0005634 | nucleus | 6.45e-01 | 1.00e+00 | -0.074 | 6 | 158 | 3246 |
GO:0005887 | integral component of plasma membrane | 6.85e-01 | 1.00e+00 | -0.162 | 1 | 8 | 575 |
GO:0016020 | membrane | 7.00e-01 | 1.00e+00 | -0.232 | 2 | 56 | 1207 |
GO:0007165 | signal transduction | 7.12e-01 | 1.00e+00 | -0.266 | 1 | 24 | 618 |
GO:0008270 | zinc ion binding | 7.70e-01 | 1.00e+00 | -0.500 | 1 | 39 | 727 |
GO:0044281 | small molecule metabolic process | 8.21e-01 | 1.00e+00 | -0.716 | 1 | 35 | 844 |
GO:0070062 | extracellular vesicular exosome | 8.54e-01 | 1.00e+00 | -0.675 | 2 | 51 | 1641 |
GO:0003677 | DNA binding | 8.56e-01 | 1.00e+00 | -0.882 | 1 | 52 | 947 |
GO:0005886 | plasma membrane | 9.78e-01 | 1.00e+00 | -1.795 | 1 | 46 | 1784 |